SARS¥¦¥¤¥ë¥¹¡Ú½Å¾ÉµÞÀ­¸ÆµÛ´ï¾É¸õ·²¡Û 

SARS¥¦¥¤¥ë¥¹

¡Ú½Å¾ÉµÞÀ­¸ÆµÛ´ï¾É¸õ·²¡Û


½Å¾ÉµÞÀ­¸ÆµÛ´ï¾É¸õ·²¡Ê¤¸¤å¤¦¤·¤ç¤¦¤­¤å¤¦¤»¤¤¤³¤­¤å¤¦¤­¤·¤ç¤¦¤³¤¦¤°¤ó, Severe Acute Respiratory Syndrome, SARS¡Ë¤Ï¡¢¿··¿ÇÙ±ê¡ÊAtypical Pneumonia, Èóŵ·¿ÇÙ±ê¡Ë¤È¤â¸Æ¤Ð¤ì¤ë¿·¼ï¤Î´¶À÷¾É¤Ç¤¢¤ê¡¢SARS¥¦¥¤¥ë¥¹¤Ë¤è¤ê°ú¤­µ¯¤³¤µ¤ì¤ë¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¡£

2002ǯ11·î¡Ê¹­½£»Ô¸ÆµÛɸ¦µæ½ê¤Ï7·î¤Èȯɽ¡Ë¤ËÃæ²Ú¿Í̱¶¦Ï¹ñ¹­Åì¾Ê¤ËȯÀ¸¤·¡¢2003ǯ7·î¤Ë¿··¿ÇÙ±êÀ©°µÀë¸À¤¬¤À¤µ¤ì¤ë¤Þ¤Ç¤Î´Ö¤Ë¡¢8,069¿Í¤¬´¶À÷¤·¡¢775¿Í¤¬»àË´¤·¤¿¡£

2002ǯÅß¡Á2003ǯ½é²Æ
2002ǯ11·î16Æü¤ËÃæ¹ñ¹­Åì¾Ê¤Ç40Âå¤ÎÇÀ¶¨¿¦°÷¤¬È¯¾É¤·¤¿Î㤬ºÇ½é¤È¸«¤é¤ì¤Æ¤¤¤ë¤¬¡¢2003ǯ5·î6Æü¤Þ¤Ç¤ËÊ󯻤µ¤ì¤¿¤È¤³¤í¤Ë¤è¤ë¤È¡¢¹­½£»Ô¸ÆµÛɸ¦µæ½ê¤ÏºÇ½é¤Î´µ¼Ô¤Ï7·î¤Ë¤µ¤«¤Î¤Ü¤ë¤Èȯɽ¤·¤Æ¤¤¤ë¤È¤Î¤³¤È¡£

11·î¤Îȯ¾É¸å¡¢Ãæ¹ñÀ¯ÉܤϤ³¤Î¼À´µ¤¬¹­¤Þ¤é¤Ê¤¤¤è¤¦¤ËÂкö¤ò¼è¤Ã¤¿¤¬¡¢WHO¤Ë¤³¤Î¾ðÊó¤òÃΤ餻¤¿¤Î¤Ï2003ǯ2·î¤Ç¤¢¤ê¡¢Ì¾ÍÀ¤È¿®ÍѤòÍî¤È¤µ¤Ê¤¤¤è¤¦¡¢Ê󯻤òµ¬À©¤·¤¿¡£¤³¤Î·ë²Ì¡¢¹ñºÝŪ¤ÊÂбþ¤¬Ã٤줿¡£Ãæ¹ñ¤Ï¸å¤Ë¤³¤Î½é´ü¤ÎÂбþ¤ÎÃÙ¤µ¤ò¼Õºá¤·¤¿¡£

4·î¾å½Ü¤ËSARS¤¬¤­¤ï¤á¤ÆÂ礭¤ÊÌäÂê¤È¤·¤Æ¥á¥Ç¥£¥¢¤Ç¼è¤ê°·¤ï¤ì¤Æ¤¤¤ëº¢¡¢Ãæ¹ñÀ¯Éܤθø¼°Êý¿Ë¤ÏÊѤï¤Ã¤¿¤¬¡¢Ë̵þ¤Î·³É±¡¤Ç¡¢¼ÂºÝ¤Î´µ¼Ô¿ô¤è¤ê¾¯¤Ê¤¯È¯É½¤·¤Æ¤¤¤¿¤Î¤¬È½ÌÀ¤·¤¿¤Î¤â¤³¤Îº¢¤Ç¤¢¤ë¡£

¶Ë¤á¤Æ¶¯¤¤°µÎϤθå¤Ç¡¢Ãæ¹ñÀ¯ÉܤϹñºÝ¸øÌ³°÷¤¬¤³¤Î·ï¤Ë´Ø¤¹¤ëÄ´ºº¤ò¹Ô¤¦¤³¤È¤ËƱ°Õ¤·¤¿¡£¤³¤ì¤Ë¤è¤ê¡¢²áÅÙ¤Îʬ»¶¡¢·Á¼°¼çµÁ¡¢¥³¥ß¥å¥Ë¥±¡¼¥·¥ç¥ó¤ÎÉÔ­¤Ê¤É¡¢¸Å¤¯¤Ê¤Ã¤¿Ãæ¹ñ¤Î°åÎÅÀ©ÅÙ¤¬Ë½¤«¤ì¤¿¡£

4·î²¼½Ü¤ËÃæ¹ñÀ¯Éܤϡ¢´µ¼Ô¤Î¿ô¤Î¤´¤Þ¤«¤·¤Ï¡¢°åÎÅÀ©ÅÙ¾å¤ÎÌäÂê¤Ç¤¢¤ë¤³¤È¤òǧ¤á¤¿¡£¾Õɧ±ÊÇî»Î¤ÏÃæ¹ñ¤Î¤â¤ß¾Ã¤·¤ò˽Ϫ¤·¤¿¡£Èà¤Ï¡¢Èà¤Îɱ¡¤À¤±¤Ç¡¢È¯É½¤µ¤ì¤Æ¤¤¤ëÃæ¹ñ¤Î´µ¼Ô¿ô¤è¤ê¤â¿¤¤´µ¼Ô¤¬¤¤¤¿¤ÈÊó¹ð¤·¤¿¡£Ë̵þ¤Î»ÔŤÈÊݸ±¶ÉŤò´Þ¤à¿¤¯¤Î¿Í¤¬²òǤ¤µ¤ì¡¢SARS¤òÄ´ºº¤·¡¢¥³¥ó¥È¥í¡¼¥ë¤¹¤ë¤è¤êÎɤ¤¥·¥¹¥Æ¥à¤¬ºî¤é¤ì¤¿¡£

¤³¤ì°Ê¹ß¡¢Ãæ¹ñ¤Ï¡¢¤è¤êÀѶËŪ¤«¤ÄÆ©ÌÀÀ­¤ò¹â¤á¤¿SARSÂкö¤ò¹Ô¤Ã¤¿¡£

¾¹ñ¤Ø¤Î³ÈÂç


SARS¤¬ÃΤé¤ì¤ë¤è¤¦¤Ë¤Ê¤Ã¤¿¤Î¤Ï2·î¤Î»ö¤Ç¤¢¤ë¡£

Ãæ¹ñ¤«¤é¤Îι¹Ô¼Ô¤Ç¤¢¤ë¡¢¥¢¥á¥ê¥«¤Î¥Ó¥¸¥Í¥¹¥Þ¥ó¤¬¡¢¥·¥ó¥¬¥Ý¡¼¥ë¤Ø¸þ¤«¤¦¹Ò¶õµ¡¤ÎÃæ¤Ç¡¢ÇÙ±ê¤Ë»÷¤¿¾É¾õ¤ò°ú¤­µ¯¤³¤·¤¿¡£Èô¹Ôµ¡¤Ï¥Ù¥È¥Ê¥à¤Î¥Ï¥Î¥¤¤ËÃåΦ¤·¤¿¤¬¡¢¥Ï¥Î¥¤¤Îɱ¡¤Ç¤³¤Îι¹Ô¼Ô¤Ï»àË´¤·¤¿¡£É±¡¤Î´ðËÜŪ¤Ê½èÃ֤ˤ⤫¤«¤ï¤é¤º¡¢Èà¤Î½èÃÖ¤ËÅö¤¿¤Ã¤¿°å»Õ¤ä´Ç¸î»Õ¤¬Æ±¤¸¾É¾õ¤ò¼¨¤·¡¢²¿¿Í¤«¤¬»àË´¤·¤¿¡£¤³¤Î¾É¸õ·²¤Îɸ¶À­¤È¡¢°åÎŽ¾»ö¼Ô¤Ø¤Î´¶À÷¤Ï¡¢À¤³¦Ãæ¤ÎÊÝ·òÅö¶É¤ò¶²¤ì¤µ¤»¤¿¡£¥Ï¥Î¥¤ºß½»¤Î¥«¥ë¥í¡¦¥¦¥ë¥Ð¥Ë¤ÏWHO¤ØÊó¹ð¤ò¹Ô¤¤¡¢2003ǯ3·î12Æü¡¢WHO¤ÏÀ¤³¦µ¬ÌϤηÙÊó¤ò½Ð¤·¤¿¡£

SARS¤Ï¥È¥í¥ó¥È¡¢¥·¥ó¥¬¥Ý¡¼¥ë¡¢¥Ï¥Î¥¤¡¢¹á¹Á¡¢ÂæÏÑ¡¢µÚ¤ÓÃæ¹ñ¤Î¹­Åì¾Ê¡¢»³À¾¾Ê¤Ë¹­¤Þ¤Ã¤¿¡£¹á¹Á¤Ç¤Î´¶À÷¸»¤Ï¡¢2·î¤Ë¥á¥È¥í¥Ý¡¼¥ë¥Û¥Æ¥ë¤Î9³¬¤Ë½ÉÇñ¤·¤¿Ãæ¹ñ¹­Åì¾Ê¤Î°å»Õ¤Ç¡¢¥Û¥Æ¥ë¤òˬ¤ì¤¿16¿Í¤Ë´¶À÷¤µ¤»¤¿¡£¤½¤ì¤é¤Îι¹Ô¼Ô¤ÏSARS¤ò¥·¥ó¥¬¥Ý¡¼¥ë¤ä¥È¥í¥ó¥È¤Ë¹­¤á¤¿¡£¤³¤ì¤¬¸µ¤Ç¡¢3·îº¢¤«¤éÀ¤³¦Åª¤ÊØí´µ¼Ô¤Î¹­¤¬¤ê¤ò¸«¤»¤¿¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¡£

¹á¹Á¤Ç¤Î¡¢ºÇ½é¤Î´¶À÷¼Ôã¤Ï2003ǯ3·î29Æü¤ËÂౡ¤·¤¿¡£

7·î5Æü¡¢WHO¤ÏºÇ¸å¤Þ¤ÇÂæÏѤ˽Фµ¤ì¤Æ¤¤¤¿´¶À÷Ã졏ȯÄê¤ò²ò½ü¤·¤¿¤¬¡¢´°Á´¤ÊÀ©°µ¤Þ¤Ç¤Ë¤Ï¤Þ¤À´ü´Ö¤òÍפ¹¤ë¤È¸«¤é¤ì¤Æ¤¤¤ë¡£¤Þ¤¿¡¢Åߤ˺ÆÎ®¹Ô¤¹¤ë²ÄǽÀ­¤¬»ØÅ¦¤µ¤ì¤Æ¤¤¤ë¡£

¼ç¤Ê¾É¾õ¤Ï¡¢38Åٰʾå¤ÎȯǮ¡¢¤»¤­¡¢¸ÆµÛº¤ÆñÅù¡£É¸¶ÂΤϿ··¿¤Î¥³¥í¥Ê¥¦¥¤¥ë¥¹¤Ç¤¢¤ë¤³¤È¤¬È½ÌÀ¡¢SARS¥¦¥¤¥ë¥¹¤È̿̾¤µ¤ì¤¿¡£

2003ǯ4·î3Æü¡¢ÆüËÜÀ¯ÉܤÏSARS¤ò¿·´¶À÷¾É¤È¤·¤Æ¼è¤ê°·¤¦¤³¤È¤òȯɽ¡¢¹¹¤Ë4·î17Æü¡¢¸¶°ø¤¬È½ÌÀ¤·¤¿¤¿¤á»ØÄê´¶À÷¾É¤ØÀڤ괹¤¨¤ëÊý¿Ë¤òȯɽ¤·¤¿¡£

2003ǯ6·î13Æü¸½ºßWHO¤¬¤È¤ê¤Þ¤È¤á¤¿¤È¤³¤í¤Ë¤è¤ë¤È¡¢´µ¼Ô¤ÎÌó 9.4% ¤¬»àË´¤·¤Æ¤ª¤ê¡¢WHO¤Î¿ä·×¤Ç¤ÏÃ×»àΨ¤Ï14¡Á15%¤Ë㤹¤ë¤È¤ß¤é¤ì¤ë¡£

2003ǯ7·î30Æü¡¢Ãæ¹ñ ¿¼圳»Ô¤ÇSARS¤ÎÌȱÖʪ¼Á¤Î¹çÀ®¤ËÀ®¸ù
2003ǯ¤ÎÀ¤³¦ÊÝ·òµ¡´Ø¤Îȯɽ:

3·î31Æü 1,622¿Í¤Î¾ÉÎã¤È58¿Í¤Î»àË´¼Ô
4·î30Æü 5,663¿Í°Ê¾å¤Îµ¿¤ï¤·¤¤´µ¼Ô¤È372¿Í¤Î»àË´¼Ô
5·î31Æü 8,360¿Í°Ê¾å¤Îµ¿¤ï¤·¤¤´µ¼Ô¤È764¿Í¤Î»àË´¼Ô
6·î13Æü 8,454¿Í°Ê¾å¤Îµ¿¤ï¤·¤¤´µ¼Ô¤È792¿Í¤Î»àË´¼Ô
ÅÁÈÂÃϰè¤ÈÎßÀÑ´µ¼ÔÊó¹ð¿ô ¡ÊWHO¡§±Ñʸ, ¡Á6·î13Æü¡Ë ¡Ê¥Æ¥­¥¹¥È¡Ë
´¶À÷¼Ô¿ô¤Î¥°¥é¥Õ ¡Ê±Ñʸ¡Ë
WHO¤Ë¤è¤ì¤Ð¡¢¥È¥í¥ó¥È¡¢¥·¥ó¥¬¥Ý¡¼¥ë¡¢ÂæÏÑ¡¢¥Ï¥Î¥¤¡¢Ãæ¹ñ¹­Åì¾Ê¡¢¹á¹Á¡¢¤½¤·¤Æ¾å³¤¤Ê¤É¤ÎÃϰè¤Ç¡¢¶ÉÃÏŪ¤ÊSARS¤Î´¶À÷³ÈÂ礬µ¯¤³¤Ã¤Æ¤¤¤ë¡£¹á¹Á¤Ç¤ÏºÇ½é¤Î´¶À÷¼Ô¤Î°ìÃĤÏ3·î29Æü¤Ë¤ÏÂౡ¤·¤Æ¤¤¤ë¡£6·î13Æü¸½ºß¤Þ¤Ç¤ÎÊó¹ð¤Ë¤è¤ë¤È¹á¹Á¤Ç¤Î²óÉüÎã¤Ï 1,380¿Í¤Ë¤Ê¤Ã¤Æ¤¤¤ë¡£

SARS¤Î´¶À÷ÊýË¡¤Ï¤Þ¤À¤Ï¤Ã¤­¤ê¤È¤Ï¤ï¤«¤Ã¤Æ¤¤¤Ê¤¤¤¬¡¢´¶À÷¼Ô¤Î¤»¤­¡¢¤Þ¤¿¤Ï¡¢¤¯¤·¤ã¤ß¤ÎÈôË÷¤òµÛ°ú¤¹¤ë¤³¤È¤Ë¤è¤ê´¶À÷¤¹¤ë¤«¡¢¤¢¤ë¤¤¤ÏÉÕÃ夷¤¿Ê¬Èçʪ¤Ø¤ÎÀÜ¿¨¤Ë¤è¤ê´¶À÷¤¹¤ë¤È¹Í¤¨¤é¤ì¤Æ¤¤¤ë¡£³Æ¹ñ¤ÎÊÝ·òµ¡´Ø¤Ï¤Þ¤¿¶õµ¤´¶À÷¤Î²ÄǽÀ­¤âÄ´ºº¤·¤Æ¤¤¤ë¡£


[ÊÔ½¸] 2003ǯÅß¡Á
2003ǯ¸åȾ°Ê¹ß¤Ï¡¢2004ǯÁ°È¾¤Þ¤Ç¤Ë·×14̾¤Î´¶À÷´µ¼Ô¤¬Êó¹ð¤µ¤ì¤Æ¤¤¤ë¡£¤³¤ÎÆâÌõ¤Ï11̾¤¬¼Â¸³»ÜÀßÅù¤Ë¤ª¤±¤ë´¶À÷»ö¸Î¤Ë¤è¤ë¤â¤Î¤Ç¡¢»Ä¤ê3̾¤Ï¤½¤ì¤¾¤ì´¶À÷·ÐÏ©ÉÔÌÀ¤ÎñȯŪ¤Ê¤â¤Î¤Ç¤¢¤ë¡£

¼Â¸³»ÜÀßÅù¤Ç¤Î»ö¸Î¤Ë¤è¤ë´¶À÷¼Ô11̾¤Î¤¦¤Á9̾¤Ï2004ǯ3·î¤«¤é4·î¤Ë¤«¤±Ãæ¹ñË̵þ¤Î¹ñΩ¥¦¥¤¥ë¥¹³Ø¸¦µæ½ê¤ÇȯÀ¸¤·¤¿¤â¤Î¤Ç¤¢¤ë¡£¤³¤ì¤Ï4·î22Æü¤Ë¸øÉ½¤µ¤ì¡¢Æ±¸¦µæ½ê¤ÏÍâÆüÊĺ¿¡¢WHO¤ÈÃæ¹ñÀ¯Éܤζ¦Æ±Ä´ºº¥Á¡¼¥à¤Ë¤êÄ´ºº¤¬³«»Ï¤µ¤ì¤¿¤¬¡¢¤·¤«¤·¤³¤ì¤âÀÜ¿¨¼Ô¤Î·ò¹¯´Æ»ëÅù¤Ë¤è¤ê´¶À÷¤Ï½ªÂ©¤·¡¢5·î18Æü¤ËWHO¤¬¼ý«Àë¸À¤ò½Ð¤¹¤Ë»ê¤Ã¤¿¡£

2008ǯ¸½ºß¡¢¤½¤Î¸å¤Î´¶À÷ȯÀ¸¤ÎÊó¹ð¤Ï¤µ¤ì¤Æ¤¤¤Ê¤¤¡£


¾É¾õ¡¦¸¶°ø¤È´¶À÷ÊýË¡


2003ǯ3·î12Æü¡¢ÊƹñCDC ¡ÊCenters for Disease Control and Prevention¡Ë ¤Î·Ù¹ð¤Ë¤Ä¤Å¤­WHO¤¬À¤³¦Åª¤Ë·Ù¹ð¤òȯ¤·¤¿¡£WHO¤Ë¤è¤ì¤Ð´¶À÷¤Îµ¿¤¤¤¬¤¢¤ë´µ¼Ô¤Ï³ÖÎ¥¤¹¤ë¤Î¤¬Ë¾¤Þ¤·¤¯¡¢°Ê²¼¤Î¤è¤¦¤Ê¥±¡¼¥¹¤ò¡Ö´¶À÷¤Îµ¿¤¤¤¢¤ê¡×¤ÈÄêµÁ¤·¤Æ¤¤¤ë¡£

¤¢¤ë¿Íʪ¤¬¡¢2003ǯ2·î1Æü°Ê¹ß:

38¡î¤òͤ¨¤ë¹âÇ®¡¢¤ª¤è¤Ó
°Ê²¼¤Î¤Ò¤È¤Ä°Ê¾å¤Ë¤¢¤Æ¤Ï¤Þ¤ë¸ÆµÛ¾å¤ÎÌäÂê: ³±ÓÖ¡¢Â©¤®¤ì¡¢¸ÆµÛº¤Æñ¡¢Äã»ÀÁÇ·ì¾É¤¢¤ë¤¤¤ÏÇٱꡢ¤ª¤è¤Ó
°Ê²¼¤Î¤Ò¤È¤Ä°Ê¾å¤Ë¤¢¤Æ¤Ï¤Þ¤ë¾ì¹ç:
SARS´¶À÷¤Îµ¿¤¤¤¬¤¢¤ë¿Íʪ¤È¤Î¶ÛÌ©¤ÊÀÜ¿¨
SARS´¶À÷µ­Ï¿¤¬¤¢¤ëÃÏ°è¤Ø¤Îι¹Ô
SARS¤Ë´Ø¤¹¤ë°ìÈÌŪ¤Ê¾È²ñ¤Ë¤Ä¤¤¤Æ¤Ï¡¢´¶À÷¾É¤ÎÀìÌç²È¤¬ÁÈ¿¥¤·¤Æ¤¤¤ëNPO¤Ç¤¢¤ë¥Ð¥¤¥ª¥á¥Ç¥£¥«¥ë¥µ¥¤¥¨¥ó¥¹¸¦µæ²ñ¡Ê¥Ð¥à¥µ¡Ë¤Ç¤â¡¢Éµ¤¼«ÂΤä¿ÇÃǸ¡ººË¡¤Ë¤Ä¤¤¤Æ±þÅú¡Ê¸¶Â§Åª¤È¤·¤Æ9»þ¡Á17»þ¡Ë¤Ç¤­¤ë¡£

Sars-corona.png


¿·¥³¥í¥Ê¥¦¥¤¥ë¥¹¤Ë¤è¤ê´¶À÷/ȯɤ¹¤ë¡£

2003ǯ4·î14Æü CDC¤ÏSARS¤ÎÀ¤³¦ÅªÎ®¹Ô¤Î¸¶°ø¤È¤µ¤ì¤Æ¤¤¤ë¥³¥í¥Ê¥¦¥¤¥ë¥¹¤Î¥²¥Î¥àÇÛÎó¤ò·èÄê[3] [4]
WHO¤ÎFAQ¤Ë¤è¤ë¤È¡¢¼ç¤ËÈôË÷´¶À÷¤Ë¤è¤Ã¤Æ¹­¤¬¤ë¡£ÈôË÷´¶À÷¤È¤Ï¶õµ¤´¶À÷¤Ç¤Ï¤Ê¤¯¡¢³±¤ä¤¯¤·¤ã¤ß¤ÇÈô¤ó¤ÀSARS´µ¼Ô¤ÎÂñդòµÛ¤¤¹þ¤à¤³¤È¤Ë¤è¤ë´¶À÷¤Ç¤¢¤ë¡£ÈôË÷¤ÏÂ礭¤¤¤¿¤á¡¢Èô¤Öµ÷Î¥¤ÏÄ̾ï1¥á¡¼¥È¥ë°ÊÆâ¡£¤·¤«¤·¡¢SARS¤Ï¶õµ¤¤ä±øÀ÷¤µ¤ì¤¿Êª¤ò²ð¤·¤Æ¤â¤Ã¤È¹­ÈϰϤ˹­¤¬¤ë²ÄǽÀ­¤â¤¢¤ë¡£

ÉáÄ̤ÎÉ÷¼Ù¥¦¥¤¥ë¥¹¤âÈôË÷´¶À÷¤Ë¤è¤Ã¤Æ¹­¤¬¤ë¡£¶õµ¤´¶À÷¤Ë¤è¤Ã¤Æ¹­¤¬¤ë¥¦¥¤¥ë¥¹¤Ë¤Ï¡¢¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¥¦¥¤¥ë¥¹¤äË㿾¥¦¥¤¥ë¥¹¤¬¤¢¤ë¡£¤·¤¿¤¬¤Ã¤Æ¡¢SARS¤Ï¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤è¤ê¤â´¶À÷Ψ¤ÏÄ㤤¤È¸À¤ï¤ì¤Æ¤¤¤ë¡£

Ä̾ï¤Î¥³¥í¥Ê¥¦¥¤¥ë¥¹¤ÏÂç³µ¤Ç3»þ´Ö°Ê¾åÀ¸¤­±ä¤Ó¤ë¤¬¡¢SARS¥¦¥¤¥ë¥¹¤Ï´¥Á礷¤¿¥×¥é¥¹¥Á¥Ã¥¯¾å¤Ç24»þ´Ö°Ê¾åÀ¸Â¸¤¹¤ë¤³¤È¤¬³Îǧ¤µ¤ì¤¿¡£

´¶À÷·ÐÏ©¤ÎÄ´ºº·ë²Ì¤Ë¤è¤ë¤È¡¢¤´¤¯°ìÉô¤Î´µ¼Ô¤¬Â¿¿ô¤Î¿Í¤Ë°Ü¤·¤¿¤È¤ß¤é¤ì¡¢¤³¤Î¤è¤¦¤Ê´µ¼Ô¤Ï¥¹¡¼¥Ñ¡¼¥¹¥×¥ì¥Ã¥À¡¼¤È¸Æ¤Ð¤ì¤Æ¤¤¤ë¤¬¡¢¤½¤ÎÍýͳ¤ò´Þ¤à´¶À÷¤Î»ÅÁȤߤϲòÌÀ¤µ¤ì¤Æ¤¤¤Ê¤¤¡£

ͽËÉ¡¦Âкö

±øÀ÷¤µ¤ì¤¿Êª¤ò¿¨¤ë¤³¤È¤Ë¤è¤ë´¶À÷¤Î¥ê¥¹¥¯¤ò¸º¤é¤¹¤¿¤á¤Ë¡¢CDC¤ÏÀи´¤È¿å¤Ç½½Ê¬¤Ë¼ê¤òÀö¤¦¤³¤È¤ò´«¤á¤Æ¤¤¤ë¡£¡ÊWHO¤ÎFAQ¤è¤ê¡Ë
ÆüËܤǤϡ¢´¶À÷¤Îµ¿¤¤¤¬¤¢¤ë¿Í¤¬¤¤¤¿¤â¤Î¤Î´¶À÷¼Ô¤¬½Ð¤Ê¤«¤Ã¤¿¡£¼êÀö¤¤¤ä¤¦¤¬¤¤¤¬´·¹Ô¤µ¤ì¤Æ¤¤¤ë¤¿¤á¤È¤¤¤¦½¬´·¤â¤¤¤ï¤ì¤¿¤¬¡¢°Ê²¼¤ÎÍýͳ¤â»ØÅ¦¤µ¤ì¤¿¡£
ÆüËܿͤ¬¾ï¿©¤·¤Æ¤¤¤ëȯ¹Ú¿©ÉÊ¡ÊÌ£Á¹¡¢¾ßÌý¡¢Ç¼Æ¦¡¢ÄÒʪ¤Ê¤É¡Ë¤Ë´Þ¤Þ¤ì¤ëÆý»À¶Ý¤¬SARS¤ËÂФ¹¤ëÌȱֵ¡Ç½¤ò²Ì¤¿¤·¤¿¤È¤â¤¤¤ï¤ì¤ë¡£¤Þ¤¿¡¢¸å½Ò¤¹¤ë¥­¥à¥Á¾ï¿©¤Î´Ú¹ñ¡¢¥Á¡¼¥º¡¢¥è¡¼¥°¥ë¥È¤ò¾ï¿©¤¹¤ë°ìÉô¤Î¥è¡¼¥í¥Ã¥Ñ½ô¹ñ¤Ç¤â´¶À÷¼Ô¤Ï°µÅÝŪ¤Ë¾¯¤Ê¤«¤Ã¤¿¤³¤È¤«¤é¡¢Æý»À¶Ý¤¬SARS¤òËɤ°¤Î¤Ç¤Ï¤Ê¤¤¤«¤È·öÅÁ¤µ¤ì¡¢Ãæ¹ñ¤Ç¤Ï¥ä¥¯¥ë¥È¤ä¥­¥à¥Á¡¢Ì£Á¹¤Ê¤É¤¬Èô¤Ö¤è¤¦¤ËÇä¤ì¤¿¤È¤¤¤¦¡£¡¡[5]
°ìÈ̤οͤˤȤäƴ¶À÷ͽËɤΤ¿¤á¤ËN95¥Þ¥¹¥¯¤òÃåÍѤ¹¤ë¤³¤È¤ÏɬÍפǤϤʤ¤¡£¡Ê2003ǯ4·î9Æü¡Ë
²ÈÄí¡¦¿¦¾ì¤Ë¤ª¤±¤ë¾ÃÆÇÎã ¡Ê´¶À÷¾É¾ðÊ󥻥󥿡¼¡Ë
½Å¾ÉµÞÀ­¸ÆµÛ´ï¾É¸õ·²¡ÊSARS¡Ë´ÉÍýÎã¡Ê4Äû¡Ë ¡Ê´¶À÷¾É¾ðÊ󥻥󥿡¼¡Ë
´Ú¹ñ¤Î¸¦µæ¼Ô¤¬¡Öȯ¹Ú¿©ÉʤǤ¢¤ë¥­¥à¥Á¤Ë SARS ¤ËÂФ¹¤ëÌȱ֤ò¶¯²½¤¹¤ë¸úǽ¤¬¤¢¤ë¡×¤Èȯɽ ¡Ê2003ǯ4·î25Æü¡Ë[2]¡£
ÆüËܹñÆâ¤Ç¤Ï¡¢½Å¾ÉµÞÀ­¸ÆµÛ´ï¾É¸õ·²¤Ë´¶À÷¤·¤¿´µ¼Ô¤òÈÂÁ÷¤¹¤ëµßµÞ¼Ö¤ä¼£ÎÅ¡¦Æþ±¡¤ò¹Ô¤¦É±¡¤¬À°È÷¤µ¤ì¤Æ¤¤¤ë¡£
2003ǯ7·î¤Ë¤Ï¡¢Æü»º¼«Æ°¼Ö¤Î´ØÏ¢²ñ¼Ò¤Ç¤¢¤ëÆü»º¼ÖÂΤ¬µþÅÔÉܤؽžɵÞÀ­¸ÆµÛ´ï¾É¸õ·²´µ¼ÔÂбþµßµÞ¼Ö¤ÎÂè1¹æ¼Ö¤ò´ó£¤·¤¿¤Î¤òÈéÀÚ¤ê¤Ë¡¢Æ±ÍͤμÖξ¤¬Â¿¤¯¤Î¼«¼£ÂÎ¤ËÆ³Æþ¤µ¤ì¤Æ¤¤¤ë¡£

¼£ÎŤϥ¦¥¤¥ë¥¹À­¼À´µ¤Ç¤¢¤ë¤Î¤Ç¹³À¸Êª¼Á¤ÎŬ±þ¤Ï¤Ê¤¤¡£

³ÖÎ¥¡£³°Éô¤è¤ê¤âµ¤°µ¤òÄ㤯¡Ê±¢°µ¥·¥¹¥Æ¥à¡Ë¤·¤Æ¤¤¤ëɬÍפ¬¤¢¤ë¡£
»à˴Ψ¤ÏÌó9.4% ¡Ê2003ǯ6·î13Æü¡Ë
¾É¾õ¤¬¾Ã¤¨¤¿¸å¤Î´µ¼Ô¤Î°·¤¤
¾É¾õ¤¬½Ð¤ëÁ°¡¢¤¢¤ë¤¤¤Ï¾É¾õ¤¬¾Ã¤¨¤¿¸å¡¢SARS´µ¼Ô¤¬¤É¤Î¤¯¤é¤¤¤Î´Ö¾¤Î¿Í¤Ëɵ¤¤ò°Ü¤¹²ÄǽÀ­¤¬¤¢¤ë¤«¤Ïʬ¤«¤Ã¤Æ¤¤¤Ê¤¤¡£¡ÊWHO¤ÎFAQ¤è¤ê¡Ë
¾É¾õ¤¬¾Ã¤¨¤¿°ì¥õ·î¸å¤ËºÆ¤Ó¾É¾õ¤¬Ìá¤Ã¤¿Î㤬¤¢¤ë¡£

¡Ý¥Õ¥ê¡¼É´²Ê»öŵ¡Ø¥¦¥£¥­¥Ú¥Ç¥£¥¢¡ÊWikipedia¡Ë¡Ù¡Ý

[2008/05/01 09:23] SARS¥¦¥¤¥ë¥¹ | TB(1) | CM(1)

bred

cool post dude <a href=" http://www.washingtontimes.com/users/tramadolman/ ">tramadol drug label</a> 8[[
[2008/11/14 17:45] bred [ ÊÔ½¸ ]

¥³¥á¥ó¥È¤ÎÅê¹Æ















´ÉÍý¼Ô¤Ë¤À¤±É½¼¨¤òµö²Ä¤¹¤ë

¥È¥é¥Ã¥¯¥Ð¥Ã¥¯

¤³¤Îµ­»ö¤Î¥È¥é¥Ã¥¯¥Ð¥Ã¥¯URL
http://tennsinoomoide.blog69.fc2.com/tb.php/258-03c67af6


¡Ú¥¦¥ë¥Ð¥Ë¡Û¤Ë¤Ä¤¤¤Æ¥µ¡¼¥Á¥¨¥ó¥¸¥ó¤Ç¸¡º÷¤·¤Æ¤ß¤ë¤È

¥¦¥ë¥Ð¥Ë ¤Ë´Ø¤¹¤ë¥Ö¥í¥°¤Î¥ê¥ó¥¯¤ò½¸¤á¤Æ¤¤¤Þ¤¹¡ªºÇ¿·¤Î¸¡º÷·ë²Ì¤ò¤Þ¤È¤á¤Æ¡¢¸ý¥³¥ß¾ðÊó¤ò¥Þ¥Ã¥·¥å¥¢¥Ã¥×¤·¡Ä
[2008/05/01 15:40] URL µ¤¤Ë¤Ê¤ë¥­¡¼¥ï¡¼¥É¤Ç¥Ö¥í¥°¸¡º÷¡ª